BMNR is trading at $32.24 (-3.31%), reflecting investor concerns ahead of the January 15 shareholder vote to increase authorized shares from 500 million to 50 billion—a massive dilution proposal.
- The proposal has sparked significant pushback from shareholders and analysts citing weak guardrails and misaligned incentives.
- The stock's weakness suggests dilution fears are currently outweighing positive crypto holdings growth, despite Ethereum rising +0.77%.
- The company continues accumulating ETH, now holding 4.11 million tokens.